Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

about

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

Item

http://www.wikidata.org/entity/Q50084092

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@en

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@nl

type

Item

label

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@en

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@nl

prefLabel

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@en

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

@nl

P1476

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT

@en

P2093

Andrew S Allegretti

http://www.w3.org/2001/XMLSchema#string

Dihua Xu

http://www.w3.org/2001/XMLSchema#string

Hannah Gilligan

http://www.w3.org/2001/XMLSchema#string

Nwamaka D Eneanya

http://www.w3.org/2001/XMLSchema#string

Ravi I Thadhani

http://www.w3.org/2001/XMLSchema#string

Sophia Zhao

http://www.w3.org/2001/XMLSchema#string

Xavier Vela Parada

http://www.w3.org/2001/XMLSchema#string

P2860

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

Terlipressin for hepatorenal syndrome

Underestimation of liver-related mortality in the United States.

Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Hepatorenal syndrome: pathophysiology and management.

P304

16-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03610417

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J L Dienstag

Raymond T Chung

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29122911

http://www.w3.org/2001/XMLSchema#string

P932

5753306

http://www.w3.org/2001/XMLSchema#string